Drug intelligence / Profile preview

Aronta

Development stage
Unknown
Lead developer
Pharmaselect International
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Aronta is an ophthalmic solution (eye drop) developed by Pharmaselect International, primarily indicated for the management of degenerative and inflammatory conditions of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The formulation is a combination of a curcumin-phospholipid complex (often utilizing phytosome technology like Meriva) and sodium hyaluronate (hyaluronic acid). Curcumin is a natural polyphenol that provides potent antioxidant and anti-inflammatory effects by inhibiting key signaling pathways, including NF-kappaB and TNF-alpha, which helps protect retinal tissues from oxidative damage and pathological angiogenesis. Sodium hyaluronate acts as a lubricant and humectant, stabilizing the tear film and providing symptomatic relief for ocular surface irritation or dry eye symptoms often associated with chronic ocular conditions. While Aronta is also widely marketed as an oral dietary supplement, the ophthalmic version is specifically designed for topical application to provide direct support to the ocular tissues.

Brand names
Aronta
Other names
Aronta eye dropsCurcumin-phospholipid complex + Sodium hyaluronate
02

Targets

NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Aronta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aronta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call